A retrospective long-term study to evaluate the outcomes in patients with severe mental disorders receiving long acting injectable risperidone

Trial Profile

A retrospective long-term study to evaluate the outcomes in patients with severe mental disorders receiving long acting injectable risperidone

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2016

At a glance

  • Drugs Risperidone (Primary)
  • Indications Mental disorders; Paranoid disorders; Psychotic disorders; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2016 New trial record
    • 20 Sep 2016 Results presented at the 29th Annual Congress of the European College of Neuropsychopharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top